222 Avsnitt

  1. Publication Presentation: Care of Congenital Melanocytic Nevi in Newborns and Infants

    Publicerades: 2022-06-28

  2. Getting to Know You: Jillian Rork, MD

    Publicerades: 2022-06-16

  3. PeDRA at 2022 Society for Investigative Dermatology

    Publicerades: 2022-06-02

  4. Hidradenitis Suppurativa Points of Discussion - Episode 3: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

    Publicerades: 2022-05-27

  5. Hidradenitis Suppurativa Points of Discussion - Episode 2: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

    Publicerades: 2022-05-27

  6. Hidradenitis Suppurativa Points of Discussion - Episode 1: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

    Publicerades: 2022-05-27

  7. Getting to Know You: Carrie Coughlin, MD, MPHS

    Publicerades: 2022-05-18

  8. Getting to Know You: PeDRA

    Publicerades: 2022-04-22

  9. Down Syndrome Points of Discussion - Episode 3: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

    Publicerades: 2022-04-06

  10. Down Syndrome Points of Discussion - Episode 2: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

    Publicerades: 2022-04-06

  11. Down Syndrome Subgroup Points of Discussion - Episode 1: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

    Publicerades: 2022-04-06

  12. Getting to Know You: Harper Price, MD

    Publicerades: 2022-03-18

  13. Early Investigator Webinar: Imposter No More

    Publicerades: 2022-03-03

  14. New Advances in the Treatment of Atopic Dermatitis in Children

    Publicerades: 2022-03-02

  15. Getting to Know You: Megha Tollefson, MD

    Publicerades: 2022-02-16

  16. Atopic Dermatitis Points of Discussion - Episode 3: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Publicerades: 2022-01-31

  17. Atopic Dermatitis Points of Discussion - Episode 2: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Publicerades: 2022-01-31

  18. Atopic Dermatitis Points of Discussion - Episode 1: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Publicerades: 2022-01-31

  19. Getting to Know You: Beth Drolet, MD

    Publicerades: 2022-01-19

  20. Neonatal Skin Points of Discussion- Episode 3: Is Sunscreen Use Safe in Infants under 6 Months?

    Publicerades: 2021-12-30

9 / 12

The Pediatric Dermatology Research Alliance (PeDRA) is vibrant research network pursuing the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.

Visit the podcast's native language site